Navigation Links
Council to honor NJIT SmartPin
Date:11/5/2007

A liquid dispensing system useful for identifying medical woes ranging from cancer to bird flu will garner an award for two NJ inventors this week. The newly-patented device will offer small and medium-sized researchers a way to test fluids cheaply, efficiently and precisely. It will also allow them a chance, at last, to analyze genes, screen for hereditary or pathogenic diseases, analyze drugs and view the characteristics of protein.

The researchers Timothy Chang, electrical and computer engineering professor at NJIT, and Peter Tolias, executive director, Institute of Genomic Medicine at UMDNJ-New Jersey Medical School, will be honored Nov. 7, 2007, by the Research and Development Council of New Jersey for their patent to develop this new system.

The duo number among more than a dozen patent holders representing industry and academe in New Jersey to be honored at the councils annual Thomas Alva Edison Awards dinner Nov. 7, 2007 at 6:30 p.m. at Dolce, a restaurant at 300 North Maple Ave., Basking Ridge. (ATTENTION EDITORS: For more information about interviews or to attend the event, call Sheryl Weinstein at 973-596-3433.)

Using our invention, these smaller firms can carry out a range of genomic and/or chemical analyses rapidly and at a low cost, said Chang. These factors are significant as these labs need no longer rely on expensive equipment and test materials or wait for the turn-around-time of off-site processing.

This is especially crucial for detecting emerging diseases such as bird flu for which quick actions must be taken. It is further anticipated that this invention will enable under-developed or developing countries to improve their disease detection and diagnostic capabilities.

This invention should help advance medical research, while lowering the cost of healthcare in the long term, said Chang.

Central to the patent is Changs active self-sensing SmartPin, which uses tiny embedded
'/>"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

Page: 1 2

Related biology news :

1. NIH hosts event to launch Council of Science Editors global theme issue
2. Lecture to honor victim of Sept. 11 tragedy
3. American Society for Microbiology honors Lucas R. Hoffman
4. American Society for Microbiology honors Joanna Kubler-Kielb
5. American Society for Microbiology honors Hung Ton-That
6. American Society for Microbiology honors Thomas E. Wellems
7. American Society for Microbiology honors Jason T. Blackard
8. American Society for Microbiology honors Michael Bruce Zwick
9. Entomological Society of America recognizes 2007 fellows and honorary members
10. UTMB researchers to be honored at Oscars of invention

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...TTE, Ind. - Researchers at Purdue University have ...rve fibers in spinal cord injuries using nano-sphe...after an accident. , The synthetic "copolymer mi...ers in diameter, or roughly 100 times smaller than... have been studying how to deliver drugs for cance...
(Date:11/6/2009)...gistration is now open for the Society of Interven...cology (IO) Therapies" Webinar, which will provide...ter treatment of liver tumors, kidney tumor ablati...nization of physicians, scientists and allied heal...lth through pioneering advances in image-guided th...
(Date:11/6/2009)...ov. 6 Auburn Hills, MI-based Law E... installing its locker system and patent-pending B....S. Department of Health and Human Services, Natio...MD. The locker system will support the NIH,s enti... our nation,s medical research agency. The projec...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter 50857 1CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter 50857 2Burnham Institute for Medical Research and Magellan BioScience Group Inc Announce Drug Discovery Collaboration 12905 1Burnham Institute for Medical Research and Magellan BioScience Group Inc Announce Drug Discovery Collaboration 12905 2Burnham Institute for Medical Research and Magellan BioScience Group Inc Announce Drug Discovery Collaboration 12905 3Symon Announces Revolutionary New Application InView Mobile 26amp 3B 238482 3B 50851 1Symon Announces Revolutionary New Application InView Mobile 26amp 3B 238482 3B 50851 2Symon Announces Revolutionary New Application InView Mobile 26amp 3B 238482 3B 50851 3
...n the cell can serve as an advanced tool for mappi...technique in which non-invasive magnetic resonance... results of this research, conducted by Prof. Mich...egulation Department, were published in the resear...Batya Cohen of the Institute,s Molecular Genetics ...
...Hopkins show that stem cell therapy can be used ef...farction, in pigs. In just two months, stem cells ...ted into the animal,s damaged heart restored heart...percent to 75 percent. , The Hopkins findings, fir...ions of the American Heart Association, are to be ...
... relative excavated last year at Petrified Forest ...ries of how and where the dinosaurs arose more tha... Period. , The animal, one of many creatures from...s thought to be an ancestor of the plant-eating or...tops, which roamed the world millions of years lat...
Other Biology News:Novel live reporting system to track cells 2Stem cell therapy successfully treats heart attack in animals 2Agilent Technologies introduces high-capacity human protein removal system for proteomics research 2Agilent Technologies introduces high-capacity human protein removal system for proteomics research 3Agilent Technologies introduces high-capacity human protein removal system for proteomics research 4
(Date:11/6/2009).... 6 ,, 3Q09 Corpor...enza(TM) E.U. Marketing Authorization to Astellas ...commercial readiness activities Expanded manageme...eting; and Director, Commercial Operations Appoin...udit Committee chairman , Upcoming 2009 Mil...
(Date:11/6/2009)...6 Intarcia Therapeutics, Inc. deli...OS® continuous delivery of exenatide) program... Annual Diabetes Technology Meeting in San Francis...in/prnh/20050301/SFTU126LOGO ) ,, Continuous ...wers Plasma Glucose, HbA1c and Reduces Weight in a...
(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...
(Date:11/5/2009)...ewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bullet...cer, President and CEO of Imagenetix, will be pres...CRO Conference on Thursday, December 3rd, at 10:30...bout LD MICRO ,, LD MICRO is a by-invitation on...lued companies in the micro-cap space. Since 2002,...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...s available for technology companies as part of a ... Standards and Technologys Advanced Technology Pr...ligible for an award, and proposals in all technol...s program are a primary source of R&D capital for ...ve an impact across several industrial and social ...
...ed today it has been chosen again to provide scori...nsin-Madisons Camp Randall Stadium and Kohl Center...uipment provided by the South Dakota-based company...eds $5 million with installation scheduled to be c...ll and 2005 Badger basketball seasons. , ,These in...
...ced today they have signed a distribution agreemen...t distributor of advanced clinical in-vitro diagno...ys distribution agreement announced last Wednesday...oal; to create innovative solutions that provide s...hly skilled team provides specialized diagnostic p...
Other Biology Technology:Daktronics to provide Camp Randall and Kohl Center with scoreboards, display systems 2
...gands\n\nReceptor-related research has long been e...abeled ligands selected to keep pace with new disc...ts and services for receptor research and drug dis...igands. If you do not find exactly what you need, ...
...ve and specific detection of microRNAs (miRNAs) by...ave high binding affinity and discrimination, enab...s. Due to the high binding affinity of the miRCURY... needed compared to traditional probes. Furthermor...
Rabbit Anti-Mouse Vitronectin Polyclonal Antibody, Unconjugated from Abcam
...methylation is an irreversible post translational ...o protein activity. At least three types of PRMT e...ese enzymes have been shown to have essential regu... several fundamental areas. These protein include ...
Biology Products: